The Valley Desk

NCT02210689 · Interventional trial

A Multi-center, Double-blind, Randomized Study, Comparing Clindamycin Phosphate Vaginal Cream 2% (Watson Laboratories, Inc.) to Clindesse® (Ther-Rx™, Clindamyin Phosphate Vaginal Cream 2%) and Both Active Treatments to a Placebo Control in the Treatment of Bacterial Vaginosis in Non-pregnant Women

Overall registry status Completed

Phase 3

Conditions BACTERIAL VAGINOSIS, Signs and Symptoms to be Evaluated and Recorded Include, Vaginal Discharge Color, Odor, and Consistency, Vulvovaginal Inflammation (Objective) Absent, Mild, Moderate, or Severe, Vulvovaginal Itching and Irritation (Subjective) Absent, Mild, Moderate, or Severe

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov